Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer
Yinli Yang, Ling Li, Zhansheng Jiang, Bin Wang, Zhanyu Pan
Topics & Concepts
Tumor microenvironmentCancer researchInnate immune systemImmunotherapyImmune systemImmune checkpointLung cancerPD-L1Cancer immunotherapyBlockadeImmunologyMedicineBiologyReceptorInternal medicineLung Cancer Research StudiesCancer Immunotherapy and BiomarkersImmune cells in cancer